Want to join the conversation?
$AMGN said that the European Commission has approved its immuno-oncology drug, IMLYGIC (talimogene laherparepvec). The drug, IMLYGIC, is used for treating deadly melanoma in adults that is regionally or distantly metastatic (Stage IIIB, IIIC and IVM1a), with no bone, brain, lung or other visceral disease.
$TXMD flying high.. anyone here to catch..?
$CMG crashing. There seems to be nothing good to read about this company.
Impressed with $AMZN’s latest grocery ambitions. The new Amazon Go convenience store, is an absolute game changer.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$